메뉴 건너뛰기




Volumn 120, Issue 3, 2010, Pages 639-648

Increased estrogen sulfatase (STS) and 17βhydroxysteroid dehydrogenase type l(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients

Author keywords

17 hydroxysteroid dehydrogenase; Aromatase inhibitors; Breast cancer; Estrogen sulfatase; Exemestane; Ki67

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN SULFATASE; ESTROGEN SULFOTRANSFERASE; EXEMESTANE; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; SULFATASE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

EID: 77950867220     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0785-3     Document Type: Article
Times cited : (44)

References (41)
  • 2
    • 33747829208 scopus 로고    scopus 로고
    • American Cancer Society . Atlanta, GA: American Cancer Society. Accessed 19 Nov 2009
    • American Cancer Society (2009) Breast Cancer Facts & Figures 2009-2010. Atlanta, GA: American Cancer Society. http://www. cancer.org/docroot/STT/STT-0.asp. Accessed 19 Nov 2009
    • (2009) Breast Cancer Facts & Figures , pp. 2009-2010
  • 3
    • 18044372636 scopus 로고    scopus 로고
    • Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer
    • Pasqualini JR, Chetrite GS (2005) Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93:221-236
    • (2005) J Steroid Biochem Mol Biol , vol.93 , pp. 221-236
    • Pasqualini, J.R.1    Chetrite, G.S.2
  • 4
    • 34548404274 scopus 로고    scopus 로고
    • New experimental models for aromatase inhibitor resistance
    • DOI 10.1016/j.jsbmb.2007.05.020, PII S0960076007001173, Proceedings of the VIII International Aromatase Conference 'Aromastase 2006' (Baltimore, Maryland USA, 18-20 September, 2006)
    • Chen S, Masri S, Hong YY, Wang X, Phung S, Yuan YC, Wu X (2007) New experimental models for aromatase inhibitor resistance. J Steroid Biochem Mol Biol 106:8-15. doi: 10.1016/j. jsbmb.2007.05.020 (Pubitemid 47362647)
    • (2007) Journal of Steroid Biochemistry and Molecular Biology , vol.106 , Issue.1-5 , pp. 8-15
    • Chen, S.1    Masri, S.2    Hong, Y.3    Wang, X.4    Phung, S.5    Yuan, Y.-C.6    Wu, X.7
  • 5
    • 61649124894 scopus 로고    scopus 로고
    • New developments in intracrinology of human breast cancer estrogen sulfatase and sulfotransferase
    • Sasano H, Nagasaki S, Miki Y, Suzuki T (2009) New developments in intracrinology of human breast cancer estrogen sulfatase and sulfotransferase. Ann NY Acad Sci 1155:76-79
    • (2009) Ann NY Acad Sci , vol.1155 , pp. 76-79
    • Sasano, H.1    Nagasaki, S.2    Miki, Y.3    Suzuki, T.4
  • 6
    • 0016264368 scopus 로고
    • Oestradiol synthesis by a human breast carcinoma
    • Miller WR, Forrest AP (1974) Oestradiol synthesis by a human breast carcinoma. Lancet 2:866-868
    • (1974) Lancet , vol.2 , pp. 866-868
    • Miller, W.R.1    Forrest, A.P.2
  • 8
    • 0036069975 scopus 로고    scopus 로고
    • Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues
    • Larionov AA, Berstein LM, Miller WR (2002) Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues. J Steroid Biochem Mol Biol 81:57-64
    • (2002) J Steroid Biochem Mol Biol , vol.81 , pp. 57-64
    • Larionov, A.A.1    Berstein, L.M.2    Miller, W.R.3
  • 9
    • 0020326596 scopus 로고
    • Significance of aromatase activity in human breast cancer
    • Miller WR, Hawkins RA, Forrest APM (1982) Significance of aromatase activity in human breast cancer. Cancer Res 42: S3365-S3368
    • (1982) Cancer Res , vol.42
    • Miller, W.R.1    Hawkins, R.A.2    Forrest, A.P.M.3
  • 11
    • 0031712804 scopus 로고    scopus 로고
    • Intratumoral aromatase in human breast, endometrial, and ovarian malignancies
    • DOI 10.1210/er.19.5.593
    • Sasano H, Harada N (1998) Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 19:593-607 (Pubitemid 28467713)
    • (1998) Endocrine Reviews , vol.19 , Issue.5 , pp. 593-607
    • Sasano, H.1    Harada, N.2
  • 12
    • 0022930325 scopus 로고
    • Enzymatic control of estrogen production in human breast cancer: Relative significance of aromatase versus sulfatase pathways
    • Santen RJ, Leszczynski D, Tilson-Mallet N, Feil PD, Wright C, Manni A, Santner S (1986) Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Ann N Y Acad Sei 464:126-137 (Pubitemid 17197627)
    • (1986) Annals of the New York Academy of Sciences , vol.VOL. 464 , pp. 126-137
    • Santen, R.J.1    Leszczynski, D.2    Tilson-Mallet, N.3
  • 13
    • 0025684712 scopus 로고
    • Relationship between tumour aromatase activity, tumour characteristics and response to therapy
    • Miller WR, Anderson TJ, Jack WJL (1990) Relationship between tumour aromatase activity, tumour characteristics and response to therapy. J Steroid Biochem Mol Biol 37:1055-1059
    • (1990) J Steroid Biochem Mol Biol , vol.37 , pp. 1055-1059
    • Miller, W.R.1    Anderson, T.J.2    Jack, W.J.L.3
  • 15
    • 33746788624 scopus 로고    scopus 로고
    • New development in intracrinology of breast carcinoma
    • Sasano H, Suzuki T, Nakata T, Moriya T (2006) New development in intracrinology of breast carcinoma. Breast Cancer 13: 129-136
    • (2006) Breast Cancer , vol.13 , pp. 129-136
    • Sasano, H.1    Suzuki, T.2    Nakata, T.3    Moriya, T.4
  • 16
    • 0043239221 scopus 로고    scopus 로고
    • Inhibition of aromatase: Insights from recent studies
    • Santen RJ (2003) Inhibition of aromatase: insights from recent studies. Steroids 68:559-567
    • (2003) Steroids , vol.68 , pp. 559-567
    • Santen, R.J.1
  • 18
    • 43149106508 scopus 로고    scopus 로고
    • Aromatase inhibitors: From bench to bedside and back
    • Geisler J (2008) Aromatase inhibitors: from bench to bedside and back. Breast Cancer 15:17-26
    • (2008) Breast Cancer , vol.15 , pp. 17-26
    • Geisler, J.1
  • 19
    • 17144423592 scopus 로고    scopus 로고
    • Aromatase inhibition: Translation into a successful therapeutic approach
    • DOI 10.1158/1078-0432.CCR-04-2187
    • Geisler J, Lønning PE (2005) Aromatase inhibition: translation into a successful therapeutic approach. Clin Cancer Res 11:28092821 (Pubitemid 40525179)
    • (2005) Clinical Cancer Research , vol.11 , Issue.8 , pp. 2809-2821
    • Geisler, J.1    Lonning, P.E.2
  • 20
    • 49649111492 scopus 로고    scopus 로고
    • Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor
    • Masri S, Phung S, Wang X, Wu X, Yuan YC, Wagman L, Chen S (2008) Genome-wide analysis of aromatase inhibitor-resistant, tamoxifen-resistant, and long-term estrogen-deprived cells reveals a role for estrogen receptor. Cancer Res 68:4910-4918
    • (2008) Cancer Res , vol.68 , pp. 4910-4918
    • Masri, S.1    Phung, S.2    Wang, X.3    Wu, X.4    Yuan, Y.C.5    Wagman, L.6    Chen, S.7
  • 21
    • 60349130840 scopus 로고    scopus 로고
    • Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?
    • Lønning PE (2009) Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation? Eur J Cancer 45:527-535
    • (2009) Eur J Cancer , vol.45 , pp. 527-535
    • Lønning, P.E.1
  • 22
    • 27944468748 scopus 로고    scopus 로고
    • Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells
    • DOI 10.1007/s10549-005-5776-4
    • Santen RJ, Lobenhofer EK, Afshari CA, Bao Y, Song RX (2005) Adaptation of estrogen-regulated genes in long-term estradiol deprived MCF-7 breast cancer cells. Breast Cancer Res Treat 94:213-223 (Pubitemid 41677626)
    • (2005) Breast Cancer Research and Treatment , vol.94 , Issue.3 , pp. 213-223
    • Santen, R.J.1    Lobenhofer, E.K.2    Afshari, C.A.3    Bao, Y.4    Song, R.X.5
  • 23
    • 77950362569 scopus 로고    scopus 로고
    • Aromatase resistance mechanisms in model system in vivo
    • doi:10.1016/j.jsbmb.2009.09.004
    • Brodie A, Macedo L, Sabnis G (2009) Aromatase resistance mechanisms in model system in vivo. J Steroid Biochem Mol Biol. doi:10.1016/j.jsbmb.2009.09. 004
    • (2009) J Steroid Biochem Mol Biol.
    • Brodie, A.1    Macedo, L.2    Sabnis, G.3
  • 24
    • 70349952517 scopus 로고    scopus 로고
    • Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors
    • Flågeng MH, Moi LL H, Dixon JM, Geisler J, Lien EA, Miller WR, Lønning PE, Mellgren G (2009) Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors. Br J Cancer 101:1253-1260
    • (2009) Br J Cancer , vol.101 , pp. 1253-1260
    • Flågeng, M.H.1    Moi, L.L.H.2    Dixon, J.M.3    Geisler, J.4    Lien, E.A.5    Miller, W.R.6    Lønning, P.E.7    Mellgren, G.8
  • 25
    • 77950862588 scopus 로고    scopus 로고
    • Neoadjuvant exemestane for 24 weeks in postmenopausal women with hormone receptor positive stage II or IUa breast cancer (JFMC34-0601) [abstract 591]
    • Sato N, Masuda N, Saji S, Takei H, Yamamoto Y, Sasano H, Toi M (2009) Neoadjuvant exemestane for 24 weeks in postmenopausal women with hormone receptor positive stage II or IUa breast cancer (JFMC34-0601) [abstract 591]. J Clin Oncol 27:15S
    • (2009) J Clin Oncol 27:15S
    • Sato, N.1    Masuda, N.2    Saji, S.3    Takei, H.4    Yamamoto, Y.5    Sasano, H.6    Toi, M.7
  • 27
    • 33645735920 scopus 로고    scopus 로고
    • Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole
    • Miller WR, White S, Dixon JM, Murray J, Renshaw L, Anderson TJ (2006) Proliferation, steroid receptors and clinical/pathological response in breast cancer treated with letrozole. Br J Cancer 94:1051-1056
    • (2006) Br J Cancer , vol.94 , pp. 1051-1056
    • Miller, W.R.1    White, S.2    Dixon, J.M.3    Murray, J.4    Renshaw, L.5    Anderson, T.J.6
  • 29
    • 0032896905 scopus 로고    scopus 로고
    • Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
    • Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474-1481
    • (1999) J Clin Oncol , vol.17 , pp. 1474-1481
    • Harvey, J.M.1    Clark, G.M.2    Osborne, C.K.3    Allred, D.C.4
  • 31
    • 36549059551 scopus 로고    scopus 로고
    • Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)
    • Takei H, Suemasu K, Inoue K, Saito T, Okubo K, Koh J, Sato K, Tsuda H, Kurosumi M, Tabei T (2008) Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03). Breast Cancer Res Treat 107:87-94
    • (2008) Breast Cancer Res Treat , vol.107 , pp. 87-94
    • Takei, H.1    Suemasu, K.2    Inoue, K.3    Saito, T.4    Okubo, K.5    Koh, J.6    Sato, K.7    Tsuda, H.8    Kurosumi, M.9    Tabei, T.10
  • 35
    • 0345314101 scopus 로고    scopus 로고
    • Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen
    • DOI 10.1016/S0959-8049(02)00600-7, PII S0959804902006007
    • Miller WR, Dixon JM, Macfarlane L, Cameron D, Anderson TJ (2003) Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen. Eur J Cancer 39:462-468 (Pubitemid 36173690)
    • (2003) European Journal of Cancer , vol.39 , Issue.4 , pp. 462-468
    • Miller, W.R.1    Dixon, J.M.2    Macfarlane, L.3    Cameron, D.4    Anderson, T.J.5
  • 39
    • 0035884620 scopus 로고    scopus 로고
    • Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- And/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: Evidence from a phase III randomized trial
    • Ellis MJ, Coop A, Singh B, Mauriac L, Llombert-Cussac A, Jänicke F, Miller WR, Evans DB, Dugan M, Brady C, QuebeFehling E, Borgs M. (2001) Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial. J CIi Oncol 19:3808-3816
    • (2001) J CIi Oncol , vol.19 , pp. 3808-3816
    • Ellis, M.J.1    Coop, A.2    Singh, B.3    Mauriac, L.4    Llombert-Cussac, A.5    Jänicke, F.6    Miller, W.R.7    Evans, D.B.8    Dugan, M.9    Brady, C.10    Quebefehling, E.11    Borgs, M.12
  • 40
    • 0034132569 scopus 로고    scopus 로고
    • 17β-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: A correlation to clinicopathological parameters
    • Suzuki T, Moriya T, Ariga N, Kaneko C, Kanazawa M, Sasano H (2000) 1 Jbeta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. Br J Cancer 82:518-523 (Pubitemid 30085183)
    • (2000) British Journal of Cancer , vol.82 , Issue.3 , pp. 518-523
    • Suzuki, T.1    Moriya, T.2    Ariga, N.3    Kaneko, C.4    Kanazawa, M.5    Sasano, H.6
  • 41
    • 60249089307 scopus 로고    scopus 로고
    • Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer
    • Aka JA, Mazumdar M, Lin SX (2009) Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer. Mol Cell Endocrinol 301: 183-190
    • (2009) Mol Cell Endocrinol , vol.301 , pp. 183-190
    • Aka, J.A.1    Mazumdar, M.2    Lin, S.X.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.